Yohei Doi, MD, PhD

Professor of Medicine
Fujita Health University School of Medicine, Japan

Poster(s):

• (371) Clinical Characteristics and Prognoses for Carbapenem-Resistant Bacterial Infections in Patients with Cancer in Japan: A Multicenter Study from the Multi-Drug Resistant Organisms Clinical Research Network (MDRnet)
  Thursday, October 12, 2023

  12:15 PM – 1:30 PM US ET

• (548) Combined Results of the Phase 2a/2b/3 Randomized Controlled Trials of Ensitrelvir for the Treatment of COVID-19 Infection
  Thursday, October 12, 2023

  12:15 PM – 1:30 PM US ET

• (549) Ensitrelvir for the Treatment of COVID-19 Infection: Evaluation of Taste Disorder and Smell Disorder in the Phase 3 Part of the Phase 2/3 SCORPIO-SR Randomized Controlled Trial
  Thursday, October 12, 2023

  12:15 PM – 1:30 PM US ET

• (719) Stenotrophomonas maltophilia in Japanese hospitals: Clinical characteristics and molecular epidemiology of infection and colonization cases registered in multicenter surveillance network
  Thursday, October 12, 2023

  12:15 PM – 1:30 PM US ET

• (2136) In Vitro Activity of Nacubactam (OP0595) Combined with Cefepime against Carbapenem-resistant Enterobacterales Isolated in Japan
  Saturday, October 14, 2023

  12:15 PM – 1:30 PM US ET